These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 20630765)

  • 1. New chloro,fluorobenzylindole derivatives as integrase strand-transfer inhibitors (INSTIs) and their mode of action.
    Ferro S; De Luca L; Barreca ML; De Grazia S; Christ F; Debyser Z; Chimirri A
    Bioorg Med Chem; 2010 Aug; 18(15):5510-8. PubMed ID: 20630765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding mode prediction of strand transfer HIV-1 integrase inhibitors using Tn5 transposase as a plausible surrogate model for HIV-1 integrase.
    Barreca ML; De Luca L; Iraci N; Chimirri A
    J Med Chem; 2006 Jun; 49(13):3994-7. PubMed ID: 16789757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacophore-based discovery of small-molecule inhibitors of protein-protein interactions between HIV-1 integrase and cellular cofactor LEDGF/p75.
    De Luca L; Barreca ML; Ferro S; Christ F; Iraci N; Gitto R; Monforte AM; Debyser Z; Chimirri A
    ChemMedChem; 2009 Aug; 4(8):1311-6. PubMed ID: 19565598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacophore-based design of HIV-1 integrase strand-transfer inhibitors.
    Barreca ML; Ferro S; Rao A; De Luca L; Zappalà M; Monforte AM; Debyser Z; Witvrouw M; Chimirri A
    J Med Chem; 2005 Nov; 48(22):7084-8. PubMed ID: 16250669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Docking studies on a new human immunodeficiency virus integrase-Mg-DNA complex: phenyl ring exploration and synthesis of 1H-benzylindole derivatives through fluorine substitutions.
    Ferro S; De Luca L; Barreca ML; Iraci N; De Grazia S; Christ F; Witvrouw M; Debyser Z; Chimirri A
    J Med Chem; 2009 Jan; 52(2):569-73. PubMed ID: 19105658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A platform for designing HIV integrase inhibitors. Part 2: a two-metal binding model as a potential mechanism of HIV integrase inhibitors.
    Kawasuji T; Fuji M; Yoshinaga T; Sato A; Fujiwara T; Kiyama R
    Bioorg Med Chem; 2006 Dec; 14(24):8420-9. PubMed ID: 17005407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tn5 transposase as a useful platform to simulate HIV-1 integrase inhibitor binding mode.
    Barreca ML; Ortuso F; Iraci N; De Luca L; Alcaro S; Chimirri A
    Biochem Biophys Res Commun; 2007 Nov; 363(3):554-60. PubMed ID: 17889829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of novel indole beta-diketo acid derivatives as HIV-1 integrase inhibitors.
    Sechi M; Derudas M; Dallocchio R; Dessì A; Bacchi A; Sannia L; Carta F; Palomba M; Ragab O; Chan C; Shoemaker R; Sei S; Dayam R; Neamati N
    J Med Chem; 2004 Oct; 47(21):5298-310. PubMed ID: 15456274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triketoacid inhibitors of HIV-integrase: a new chemotype useful for probing the integrase pharmacophore.
    Walker MA; Johnson T; Ma Z; Banville J; Remillard R; Kim O; Zhang Y; Staab A; Wong H; Torri A; Samanta H; Lin Z; Deminie C; Terry B; Krystal M; Meanwell N
    Bioorg Med Chem Lett; 2006 Jun; 16(11):2920-4. PubMed ID: 16546383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induced-fit docking approach provides insight into the binding mode and mechanism of action of HIV-1 integrase inhibitors.
    Barreca ML; Iraci N; De Luca L; Chimirri A
    ChemMedChem; 2009 Sep; 4(9):1446-56. PubMed ID: 19544345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Docking-based 3D-QSAR study of HIV-1 integrase inhibitors.
    Gupta P; Roy N; Garg P
    Eur J Med Chem; 2009 Nov; 44(11):4276-87. PubMed ID: 19647906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A refined pharmacophore model for HIV-1 integrase inhibitors: Optimization of potency in the 1H-benzylindole series.
    De Luca L; Barreca ML; Ferro S; Iraci N; Michiels M; Christ F; Debyser Z; Witvrouw M; Chimirri A
    Bioorg Med Chem Lett; 2008 May; 18(9):2891-5. PubMed ID: 18417342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and optimization of tricyclic phtalimide analogues as novel inhibitors of HIV-1 integrase.
    Verschueren WG; Dierynck I; Amssoms KI; Hu L; Boonants PM; Pille GM; Daeyaert FF; Hertogs K; Surleraux DL; Wigerinck PB
    J Med Chem; 2005 Mar; 48(6):1930-40. PubMed ID: 15771437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A platform for designing HIV integrase inhibitors. Part 1: 2-hydroxy-3-heteroaryl acrylic acid derivatives as novel HIV integrase inhibitor and modeling of hydrophilic and hydrophobic pharmacophores.
    Kawasuji T; Yoshinaga T; Sato A; Yodo M; Fujiwara T; Kiyama R
    Bioorg Med Chem; 2006 Dec; 14(24):8430-45. PubMed ID: 17010623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the molecular mechanism of cross-resistance to HIV-1 integrase strand transfer inhibitors by molecular dynamics simulation and residue interaction network analysis.
    Xue W; Jin X; Ning L; Wang M; Liu H; Yao X
    J Chem Inf Model; 2013 Jan; 53(1):210-22. PubMed ID: 23231029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, biological evaluation and molecular modeling studies of quinolonyl diketo acid derivatives: new structural insight into the HIV-1 integrase inhibition.
    Vandurm P; Guiguen A; Cauvin C; Georges B; Le Van K; Michaux C; Cardona C; Mbemba G; Mouscadet JF; Hevesi L; Van Lint C; Wouters J
    Eur J Med Chem; 2011 May; 46(5):1749-56. PubMed ID: 21385662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-Silico docking of HIV-1 integrase inhibitors reveals a novel drug type acting on an enzyme/DNA reaction intermediate.
    Savarino A
    Retrovirology; 2007 Mar; 4():21. PubMed ID: 17374162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational design of 2-pyrrolinones as inhibitors of HIV-1 integrase.
    Ma K; Wang P; Fu W; Wan X; Zhou L; Chu Y; Ye D
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6724-7. PubMed ID: 21996518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of novel β-diketo derivatives as HIV-1 integrase inhibitors.
    Hu L; Zhang S; He X; Luo Z; Wang X; Liu W; Qin X
    Bioorg Med Chem; 2012 Jan; 20(1):177-82. PubMed ID: 22154762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amide-containing diketoacids as HIV-1 integrase inhibitors: synthesis, structure-activity relationship analysis, and biological activity.
    Li H; Wang C; Sanchez T; Tan Y; Jiang C; Neamati N; Zhao G
    Bioorg Med Chem; 2009 Apr; 17(7):2913-9. PubMed ID: 19269185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.